The company received positive results from the phase 2 clinical study and that's what makes this stock went supernova. But 150%+ spike in two days just because of the positive results from their drug test NOT even a FDA approval, seems over-extended to me. Plus, the CEO and insiders sold their shares around $10-12 on the first day of its spike that means the insiders don't even think that their company should worth $17 or higher, it just my opinion. While I'm typing this the stock drop to $13